Jinghua Weikang Capsule Protects Against Helicobacter Pylori-Induced Inflammatory Responses Via the Nuclear Factor-Kappa B Signaling Pathway.

Shi Zongming,Ye Hui,Yu Jing,Cheng Hong,Li Jiang,Zhang Xuezhi

DOI: https://doi.org/10.1016/j.jtcm.2018.03.001

2018-01-01

Abstract:OBJECTIVE: To investigate the inhibitory effect of Jinghua Weikang capsule (JWC) on gastric inflammation induced by Helicobacter pylori (H. pylori) via the nuclear factor-kappa B (NE-kappa B) signaling pathway in Kunming mice. METHODS: We investigated the anti-inflammation potential of JWC extract in vivo in a H. pylori-induced gastritis mouse model. The expression of inflammation-related molecules was evaluated by Western blotting, and the concentrations of in vivo inflammatory markers were measured by enzyme -linked immunosorbent assay. Inflammatory cell infiltration was evaluated by histopathological examination, and mRNA levels of related genes were evaluated by quantitative reverse transcrip-tion polymerase chain reaction. RESULTS: JWC had a dose-dependent protective effect against H. pylori-induced gastritis by protecting gastric epithelial cells and inhibiting inflammatory cell infiltration. Mechanistically, JWC decreased the protein levels of phosphorylated IKBa and NF-kappa B p65, mRNA levels of NF-kappa B pathway molecules, and plasma levels of tumor necrosis factor-alpha and interleukin 1 beta. CONCLUSION: An important finding of our study is that JWC attenuated gastrointestinal inflammation and ulceration and exerted a protective effect against gastric injury via inhibition of inflammation reactions and regulating the canonical NF-kappa B signaling pathway in vivo. (C) 2018 JTCM. All rights reserved.